Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Erythropoietin Mitigates Diabetic Nephropathy by Restoring PINK1/Parkin-Mediated Mitophagy
Xinyao Yi, Wenhui Yan, Tingli Guo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21

Showing 21 citing articles:

The impact of oxidative stress-induced mitochondrial dysfunction on diabetic microvascular complications
Ziwei Zhang, Qingxia Huang, Daqing Zhao, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 79
Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis
Tingli Guo, Wenhui Yan, Xin Cui, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 30
Placental Mesenchymal Stem Cells Alleviate Podocyte Injury in Diabetic Kidney Disease by Modulating Mitophagy via the SIRT1-PGC-1alpha-TFAM Pathway
Xiudan Han, Jiao Wang, Ruilin Li, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4696-4696
Open Access | Times Cited: 29
An aldose reductase inhibitor, WJ-39, ameliorates renal tubular injury in diabetic nephropathy by activating PINK1/Parkin signaling
Luxi Yang, Liangting Xu, Xin Hao, et al.
European Journal of Pharmacology (2024) Vol. 967, pp. 176376-176376
Closed Access | Times Cited: 5
ALOX15 Aggravates Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice with Type 2 Diabetes via Activating the PPARγ/CD36 Axis
Wenhui Yan, Xin Cui, Tingli Guo, et al.
Antioxidants and Redox Signaling (2025)
Closed Access
Broadening horizons: the contribution of mitochondria-associated endoplasmic reticulum membrane (MAM) dysfunction in diabetic kidney disease
Yong Liu, Yingjin Qiao, Shaokang Pan, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 14, pp. 4427-4441
Open Access | Times Cited: 12
Cardioprotective Effects of hUCMSCs-Exosi-EGR1 MN Patch in MI/RI by Modulating Oxidative Stress and Mitophagy
Chenyang Huang, Xun Zhang, Shi-Xiong Wu, et al.
Materials Today Bio (2025) Vol. 31, pp. 101500-101500
Open Access
Autophagy and Mitophagy in Diabetic Kidney Disease—A Literature Review
Alina Mihaela Stăniguţ, Liliana Tuţă, C Panà, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 806-806
Open Access
Important regulatory role of mitophagy in diabetic microvascular complications
Xiaohan Hu, Jiao Lv, Yunyun Zhao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Defective PINK1-dependent mitophagy is involved in high glucose-induced neurotoxicity
Yongsheng Bian, Yimei Yang, Jun Chen, et al.
Neuroscience (2025)
Closed Access
Urolithin A enhances diabetic wound healing: Insights from parkin-mediated mitophagy in endothelial progenitor cells
Fang Xia, Zhenxuan Shao, Hongfeng Ding, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114572-114572
Closed Access
Roles of Mitochondrial Dysfunction in Diabetic Kidney Disease: New Perspectives from Mechanism to Therapy
Yichen Yang, Jiahui Liu, Qiling Shi, et al.
Biomolecules (2024) Vol. 14, Iss. 6, pp. 733-733
Open Access | Times Cited: 3
High glucose- or AGE-induced oxidative stress inhibits hippocampal neuronal mitophagy through the Keap1–Nrf2–PHB2 pathway in diabetic encephalopathy
Shan Xu, Zhaoyu Gao, Lei Jiang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Renal aging and mitochondrial quality control
Xiuli Guo, Jiao Wang, Yinjie Wu, et al.
Biogerontology (2024) Vol. 25, Iss. 3, pp. 399-414
Closed Access | Times Cited: 2
Mitochondrial proteins as therapeutic targets in diabetic ketoacidosis: evidence from Mendelian randomization analysis
Ruiqiang Xie, Hongyan Xie, Hong Gao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Mitophagy, Inflammasomes and Their Interaction in Kidney Diseases: A Comprehensive Review of Experimental Studies
Yulin Wang, Dongxu Song, Lin Tang
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 1457-1469
Open Access | Times Cited: 5
PTEN-induced kinase 1 exerts protective effects in diabetic kidney disease by attenuating mitochondrial dysfunction and necroptosis
Min Ji Sung, Hyun−Ju An, Min Heui Ha, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 16, pp. 5145-5159
Open Access | Times Cited: 4
Baicalein: A potential GLP-1R agonist improves cognitive disorder of diabetes through mitophagy enhancement
Na Liu, Xin Cui, Wenhui Yan, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 8, pp. 100968-100968
Open Access | Times Cited: 1
Chinese botanical drugs targeting mitophagy to alleviate diabetic kidney disease, a comprehensive review
Leilei Ma, Jing Li, Xiaotian Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Mitophagy involved the biological processes of hormones
Yifei Ma, Zheng Ying, Ying Zhou, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115468-115468
Open Access | Times Cited: 3
Early use of SGLT2 inhibitors reduces the progression of diabetic kidney disease: a retrospective cohort study
Shaowei Pang, Xiaoli Li
American Journal of Translational Research (2024) Vol. 16, Iss. 9, pp. 4967-4978
Closed Access
Page 1

Scroll to top